NaCl and KCl Mediate Log Increase in AAV Vector Particles and Infectious Titers in a Specific/timely Manner with the HSV Platform
Overview
Authors
Affiliations
The increasing demand for adeno-associated virus (AAV) vectors, a result from the surging interest for their potential to cure human genetic diseases by gene transfer, tumbled on low-performing production systems. Innovative improvements to increase both yield and quality of the vector produced have become a priority undertaking in the field. In a previous study, we showed that adding a specific concentration of sodium chloride (NaCl) to the production medium resulted in a dramatic increase of AAV vector particle and infectious titers when using the herpes simplex virus (HSV) production system, both in adherent or suspension platforms. In this work, we studied additional salts and their impact on AAV vector production. We found that potassium chloride (KCl), or a combination of KCl and NaCl, resulted in the highest increase in AAV vector production. We determined that the salt-mediated effect was the most impactful when the salt was present between 8 and approximately 16 h post-infection, with the highest rate increase occurring within the first 24 h of the production cycle. We showed that the AAV vector yield increase did not result from an increase in cell growth, size, or viability. Furthermore, we demonstrated that the impact on AAV vector production was specifically mediated by NaCl and KCl independently of their impact on the osmolality of the production media. Our findings convincingly showed that NaCl and KCl were uniquely efficacious to promote up to a 10-fold increase in the production of highly infectious AAV vectors when produced in the presence of HSV. We think that this study will provide unique and important new insights in AAV biology toward the establishment of more successful production protocols.
Repeated harvest enables efficient production of VSV-GP.
Habisch R, Neubauer P, Soza-Ried J, Puschmann E Front Bioeng Biotechnol. 2024; 12:1505338.
PMID: 39703791 PMC: 11656157. DOI: 10.3389/fbioe.2024.1505338.
Lin Y, Kuo H, Lu M, Rungkittikhun C, Hu W Biotechnol Bioeng. 2024; 122(2):424-434.
PMID: 39578398 PMC: 11718424. DOI: 10.1002/bit.28885.
Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.
Matsuzaka Y, Yashiro R Curr Issues Mol Biol. 2024; 46(8):8464-8498.
PMID: 39194716 PMC: 11353222. DOI: 10.3390/cimb46080499.
Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines.
Trivedi P, Byrne B, Corti M Viruses. 2023; 15(12).
PMID: 38140619 PMC: 10747483. DOI: 10.3390/v15122378.
N-glycomic profiling of capsid proteins from Adeno-Associated Virus serotypes.
Xie Y, Butler M Glycobiology. 2023; 34(1).
PMID: 37774344 PMC: 10950483. DOI: 10.1093/glycob/cwad074.